ATLID (ATmospheric LIDar) is the atmospheric backscatter LIDAR (Light Detection and Ranging) on board of the EarthCARE (Earth Cloud, Aerosol and Radiation Explorer) mission, the sixth Earth Explorer Mission of the ESA (European Space Agency) Living Planet Programme [1-5]. ATLID’s purpose is to provide vertical profiles of optically thin cloud and aerosol layers, as well as the altitude of cloud boundaries [6-10]. In order to achieve this objective ATLID emits short duration laser pulses in the UV, at a repetition rate of 51 Hz, while pointing in a near nadir direction along track of the satellite trajectory. The atmospheric backscatter signal is then collected by its 620 mm aperture telescope, filtered through the optics of the instrument focal plane assembly, in order to separate and measure the atmospheric Mie and Rayleigh scattering signals. With the completion of the full instrument assembly in 2019, ATLID has been subjected to an ambient performance test campaign, followed by a successful environmental qualification test campaign, including performance calibration and characterization in thermal vacuum conditions. In this paper the design and operational principle of ATLID is recalled and the major performance test results are presented, addressing the main key receiver and emitter characteristics. Finally, the estimated instrument, in-orbit, flight predictions are presented; these indicate compliance of the ALTID instrument performance against its specification and that it will meet its mission science objectives for the EarthCARE mission, to be launched in 2023.

The Serra da Estrela Natural Park (NPSEs) in Portugal stands out as a well-preserved region abundant in medicinal plants, particularly known for their pharmaceutical applications in diabetes prevention and treatment. This comprehensive review explores these plants' botanical diversity, traditional uses, pharmacological applications, and chemical composition. The NPSEs boast a rich diversity with 138 medicinal plants across 55 families identified as traditionally and pharmacologically used against diabetes globally. Notably, the Asteraceae and Lamiaceae families are prevalent in anti-diabetic applications. In vitro studies reveal their significant inhibition of carbohydrate-metabolizing enzymes, and certain plant co-products regulate genes involved in carbohydrate metabolism and insulin secretion. In vivo trials demonstrate anti-diabetic effects, including glycaemia regulation, insulin secretion, antioxidant activity, and lipid profile modulation. Medicinal plants in NPSE exhibit various activities beyond anti-diabetic, such as antioxidant, anti-inflammatory, antibacterial, anticancer, and more. Chemical analysis identifies over fifty compounds like phenolic acids, flavonoids, terpenoids, and polysaccharides responsible for their efficacy against diabetes. The findings underscore the potential of NPSE medicinal plants as anti-diabetic candidates, urging further research to develop effective plant-based anti-diabetic drugs, beverages, and supplements.